Skip to main content

Solventum Corp

corporate_fare Company Profile

Solventum Corp

SOLV·NYSE·Industrial Applications And Services·CIK 0001964738

Solventum Corporation is a global healthcare company that develops, manufactures, and sells a wide range of solutions. The company uses material science, data science, and digital capabilities to meet customer and patient needs, aiming to improve healthcare standards through innovation, clinical intelligence, technology, and manufacturing expertise. With over 70 years of experience, Solventum's solutions are used daily in the global healthcare industry to provide higher-quality patient care, more efficient processes, and improved safety and accuracy. Their products and services support patients through prevention, diagnosis, treatment, and recovery. Solventum serves a diverse customer base, from multidisciplinary hospitals to local clinics, leveraging strong customer relationships, a broad portfolio of brands, and differentiated technology. The company is organized into three reportable operating business segments. MedSurg, which accounted for 57.9% of 2025 total sales, provides solutions such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). These solutions are designed to accelerate healing, prevent complications, and lower the total cost of care, with surgical solutions also mitigating infection risk. Dental Solutions, representing 16.2% of 2025 total sales, offers a comprehensive suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents, covering preventative care, direct and indirect restoration, and orthodontic needs.

Solventum Corp (NYSE:SOLV) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for SOLV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-05, rated 9/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for SOLV spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Solventum to Spin Off Healthcare Software Unit, Lifts Profit Outlook
  • Solventum Q2 Earnings Beat Overshadowed by $204M Legal Charge and Health IT Spin-Off Plan
  • Solventum Q2 Profit Rises, Lifts Full-Year Sales Outlook
  • Solventum Q1 GAAP Net Income Plunges 90% to $13M, EPS Down 91%
  • Solventum Reports Sharp Q1 GAAP Profit Decline and Negative Operating Cash Flow

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$8.32B
Net Income
$1.56B
Diluted EPS
$8.88
Op. Cash Flow
$369M
Free Cash Flow
-$10M
Gross Profit
$4.45B
Operating Income
$2.18B
Cash & Equivalents
$878M
Total Debt
$5.04B
Debt / Equity
1.00×
Net Margin
18.7%
Shares Outstanding
173.49M sh
Source: 10-K · filed 2026-02-27 · accession 0001964738-26-000007
Browse all tickers starting with S →
$88.84
52-week range · as of 2026-08-05 $62.38 – $88.84
Market cap
$15.12B
Volume
2.3M (2.3× avg)
3-mo avg 1M
Live data · 2026-09-20 11:39 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SOLV - Latest Insights

SOLV
Aug 05, 2026, 6:11 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $90.42
Real-time Price: $88.84 info
Change: -$1.58 (-2%) info
Market Cap: $15.123B info
SOLV
Aug 05, 2026, 5:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $90.42
Real-time Price: $88.84 info
Change: -$1.58 (-2%) info
Market Cap: $15.123B info
SOLV
Aug 05, 2026, 5:15 PM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $90.48
Real-time Price: $88.84 info
Change: -$1.64 (-2%) info
Market Cap: $15.123B info
SOLV
May 05, 2026, 5:31 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $67.07
Real-time Price: $88.84 info
Change: +$21.77 (+32%) info
Market Cap: $15.123B info
SOLV
May 05, 2026, 5:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $67.11
Real-time Price: $88.84 info
Change: +$21.73 (+32%) info
Market Cap: $15.123B info
SOLV
May 05, 2026, 5:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $67.07
Real-time Price: $88.84 info
Change: +$21.77 (+32%) info
Market Cap: $15.123B info
SOLV
May 05, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $69.04
Real-time Price: $88.84 info
Change: +$19.80 (+29%) info
Market Cap: $15.123B info
SOLV
May 05, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $67.07
Real-time Price: $88.84 info
Change: +$21.77 (+32%) info
Market Cap: $15.123B info
SOLV
May 01, 2026, 11:20 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $66.98
Real-time Price: $88.84 info
Change: +$21.87 (+33%) info
Market Cap: $15.123B info
SOLV
Feb 27, 2026, 1:40 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $73.34
Real-time Price: $88.84 info
Change: +$15.50 (+21%) info
Market Cap: $15.123B info
SOLV
Feb 26, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $76.94
Real-time Price: $88.84 info
Change: +$11.90 (+15%) info
Market Cap: $15.123B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets